Vasopressin release and water metabolism in patients with cirrhosis.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Hepatology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0168-8278(94)80245-9PMID 7890899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Kidney in liver disease

  1996cited by this paper
• Regulation of vasopressin release in moderately severe essential hypertension

  1991cited by this paper
• Effect of intrathoracic pressure on plasma arginine vasopressin levels.

  1991cited by this paper
• Antidiuretic hormone and renal function after water loading in patients with cirrhosis of the liver.

  1991cited by this paper
• Antidiuretic effect of subnormal levels of arginine vasopressin in normal humans.

  1990cited by this paper
• Osmotic thresholds for AVP release with the use of plasma and urine AVP and free water clearance.

  1989cited by this paper
• Pathogenesis of clinical hyponatremia: observations of vasopressin and fluid intake in 100 hyponatremic medical patients

  1987cited by this paper
• Nonosmotic influences on osmotic stimulation of vasopressin in humans.

  1987cited by this paper
• Impaired renal water excretion in early hepatic cirrhosis. Lack of relationship between renal water excretion and plasma levels of arginine vasopressin, angiotensin II, and aldosterone after water loading.

  1986cited by this paper
• The osmotic thresholds for thirst and vasopressin release are similar in healthy man.

  1986cited by this paper
• Effect of volume expansion on hemodynamics, capillary permeability and renal function in conscious, cirrhotic rats

  1986cited by this paper
• Handbook of Physiology—The Cardiovascular System

  1985cited by this paper
• Inhibitory Influences from Arterial Baroreceptors on Vasopressin Release Elicited by Fastigial Stimulation in Rats

  1984cited by this paper
• Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis.

  1984cited by this paper
• Relationship between plasma arginine vasopressin and renal water handling in decompensated cirrhosis.

  1984cited by this paper
• Metabolism and secretion of antidiuretic hormone in patients with renal failure, cardiac insufficiency, and liver insufficiency.

  1984cited by this paper
• Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting.

  1983cited by this paper
• Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting

  1983cited by this paper
• Role of vasopressin in abnormal water excretion in cirrhotic patients.

  1982cited by this paper
• Integrated actions of renal medullary prostaglandins in the control of water excretion.

  1981cited by this paper
• Osmotic and nonosmotic control of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid, and edematous disorders.

  1981cited by this paper
• Disorders of water metabolism.

  1980cited by this paper
• Demeclocycline Treatment of Water Retention in Cirrhosis

  1976cited by this paper
• Letter: Demeclocycline treatment of water retention in cirrhosis.

  1976cited by this paper
• The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man.

  1976cited by this paper
• Hemodynamic and respiratory alterations with increased intra-abdominal pressure.

  1976cited by this paper
• Negative influences of ascites on the cardiac function of cirrhotic patients.

  1975cited by this paper
• A rational approach to the treatment of ascites

  1975cited by this paper
• Mechanism of effect of prostaglandin E 1 on renal water excretion.

  1973cited by this paper
• Demeclocycline-induced nephrogenic diabetes insipidus. In-vivo and in-vitro studies.

  1973cited by this paper
• Renal concentrating ability in cirrhosis III.Failure of hypertonic saline to increase reduced TcH2O formation

  1972cited by this paper
• Renal concentrating ability in cirrhosis. 3. Failure of hypertonic saline to increase reduced T C H 2 O formation.

  1972cited by this paper
• The role of vasopressin and urea in the renal concentrating defect of patients with cirrhosis of the liver.

  1971cited by this paper
• Renal function changes in cirrhosis of the liver. A prospective study.

  1970cited by this paper
• Renal concentrating ability in cirrhosis. I. Changes associated with the clinical status and course of the disease.

  1967cited by this paper
• ON THE CONCENTRATING DEFECT IN CIRRHOSIS OF THE LIVER.

  1964cited by this paper
• The effect of changing serum osmolality on the release of antidiuretic hormone in certain patients with decompensated cirrhosis of the liver and low serum osmolality.

  1959cited by this paper
• Production of hypertonic urine in the absence of pituitary antidiuretic hormone.

  1957cited by this paper
• Correction of impaired water excretion in cirrhosis of the liver by alcohol ingestion or expansion of extracellular fluid volume: the role of the antidiuretic hormone.

  1956cited by this paper
• CHANGES OF THE WATER TOLERANCE TEST IN HEPATIC DISEASE

  1943cited by this paper

• Interaction of inflammation and portal hypertension in cirrhosis progression

  2025cites this paper
• Hemodynamic Management with Vasopressin for Cardiovascular Surgery

  2024cites this paper
• Long-term administration of Tolvaptan to patients with decompensated cirrhosis

  2020cites this paper
• Serum Sodium Concentration Profile in Cirrhotic Patients and its Effect on the Prognostic Value of the MELD Score

  2017cites this paper
• Predictive value of the efficacy of tolvaptan in liver cirrhosis patients using free water clearance.

  2015cites this paper
• Hyponatremia and other electrolyte/ion disorders

  2015cites this paper
• Terlipressin facilitates gastric and autonomic system dysfunctions in liver cirrhosis.

  2011cites this paper
• Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis

  2010cites this paper
• Approach to the Patient with Ascites

  2010cites this paper
• Nonpeptide vasopressin antagonists: a new group of hormone blockers entering the scene.

  2009cites this paper
• Hyponatremia in liver cirrhosis: pathophysiological principles of management.

  2005cites this paper
• Renal dysfunction in cirrhosis: diagnosis, treatment and prevention.

  2004cites this paper
• Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.

  2003cites this paper
• A vasopressin receptor antagonist (VPA‐985) improves serum sodium concentration in patients with hyponatremia: A multicenter, randomized, placebo‐controlled trial

  2003cites this paper
• Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites

  2002cites this paper
• Pathogenesis of ascites and predictors of resistance to therapy

  2002cites this paper
• Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis.

  2001cites this paper
• Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients.

  2000cites this paper
• Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.

  2000cites this paper
• Hepatorenal syndrome and ascites--questions and answers.

  1999cites this paper
• Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment

  1999cites this paper
• Neurohumoral fluid regulation in chronic liver disease.

  1998cites this paper
• Haemodynamics and fluid retention in liver disease.

  1998cites this paper
• Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration

  1997cites this paper
• Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51,599), in rats with cirrhosis

  1996cites this paper
• Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis.

  1996cites this paper
• Assays for Vasopressin

  1996cites this paper